This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Eli Lilly and Company. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of David Andrew Cox
Introduction
David Andrew Cox is a notable inventor based in Batesville, Indiana, known for his contributions to the field of pharmaceuticals. He has made significant strides in the development of new methods and compositions that enhance the efficacy of dulaglutide, a medication used for treating diabetes.
Latest Patents
Cox holds a patent for "Methods of using and compositions containing dulaglutide." This invention focuses on the application of new doses of dulaglutide and the formulations that incorporate these higher doses, aiming to improve patient outcomes in diabetes management.
Career Highlights
Cox is affiliated with Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to engage in cutting-edge research and development, contributing to advancements in medical treatments.
Collaborations
Cox has collaborated with esteemed colleagues such as Zvonko Milicevic and Lai San Tham, enhancing the innovative efforts within his team at Eli Lilly.
Conclusion
David Andrew Cox's work exemplifies the impact of innovation in the pharmaceutical industry, particularly in the development of effective treatments for diabetes. His contributions continue to shape the future of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile